Abbott Settles Formula Probe for 384 Million
Abbott Laboratories agreed to pay over 384 million dollars to resolve claims it manufactured infant formula in risky conditions. The settlement closes a federal probe following a 2022 product recall.
Xurve View
Insights:
Xurve View
Abbott Laboratories agreed to pay $384M to settle allegations it sold contaminated infant formula to federal programs, the United States Justice Department said on Monday evening.
